Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Muñiz, P.
Right arrow Articles by Díez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muñiz, P.
Right arrow Articles by Díez, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 14-17
© 2001 European Renal Association-European Dialysis and Transplant Association

Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth

Paula Muñiz, Ana Fortuño, Guillermo Zalba, M. Antonia Fortuño and Javier Díez

Division of Cardiovascular Pathophysiology, School of Medicine, University of Navarra, Pamplona, Spain

Background. Torasemide and furosemide are diuretics that inhibit the Na+, K+, 2Cl- co-transporter localized in cells from the ascending limb of the loop of Henle. The effects of torasemide and furosemide on cell growth induced by angiotensin II (Ang II) were investigated in cultured vascular smooth muscle cells (VSMCs) obtained from the aorta of adult spontaneously hypertensive rats (SHR).

Methods. Cell growth was determined by DNA and protein synthesis as measured by [3H]thymidine and [3H]leucine incorporation, respectively. Proliferation of VSMCs was measured using a non-radioactive colorimetric cell proliferation assay.

Results. Ang II (10-7 M) signficantly increased DNA and protein synthesis and cell proliferation in VSMCs. These effects were completely abolished by the Ang II type 1 receptor antagonist irbesartan (10-6 M). Ang II-induced [3H]leucine incorporation was reduced in a dose-dependent way by torasemide (IC50 value: 7.7±0.8x10-7 M) but not by furosemide. Neither torasemide nor furosemide modified Ang II-stimulated [3H]thymidine incorporation or proliferation in VSMCs.

Conclusions. These results indicate that torasemide, but not furosemide, inhibits Ang II-induced protein synthesis in VSMCs from SHR. Thus, it is suggested that the capacity of torasemide to block this trophic action of Ang II in rat VSMCs is not mediated by inhibition of the Na+, K+, 2Cl- co-transport mechanism.

Keywords: angiotensin II; furosemide; irbesartan; smooth muscle cells; spontaneously hypertensive rats; torasemide

Correspondence and offprint requests to: Javier Díez, MD, PhD, División de Fisiopatología Cardiovascular, Facultad de Medicina, C/Irunlarrea s/n, 31008 Pamplona, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. Lopez, A. Gonzalez, J. Beaumont, R. Querejeta, M. Larman, and J. Diez
Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure
J. Am. Coll. Cardiol., August 28, 2007; 50(9): 859 - 867.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Lopez, R. Querejeta, A. Gonzalez, E. Sanchez, M. Larman, and J. Diez
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2028 - 2035.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.